Cargando…

The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis

AIMS: This study aims to evaluate the diagnostic value of blood metagenomic next-generation sequencing (mNGS) in detecting pathogens from patients clinically diagnosed as acute hematogenous osteomyelitis (AHO). METHODS: This retrospective study enrolled 66 patients with AHO. The test results of mNGS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bingshi, Chen, Xiao, Yao, Xiaowei, Li, Mengnan, Li, Zhijie, Liu, Bo, Liu, Sikai, Liu, Zeming, Huo, Jia, Han, Yongtai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911542/
https://www.ncbi.nlm.nih.gov/pubmed/36779189
http://dx.doi.org/10.3389/fcimb.2023.1106097
_version_ 1784885011762118656
author Zhang, Bingshi
Chen, Xiao
Yao, Xiaowei
Li, Mengnan
Li, Zhijie
Liu, Bo
Liu, Sikai
Liu, Zeming
Huo, Jia
Han, Yongtai
author_facet Zhang, Bingshi
Chen, Xiao
Yao, Xiaowei
Li, Mengnan
Li, Zhijie
Liu, Bo
Liu, Sikai
Liu, Zeming
Huo, Jia
Han, Yongtai
author_sort Zhang, Bingshi
collection PubMed
description AIMS: This study aims to evaluate the diagnostic value of blood metagenomic next-generation sequencing (mNGS) in detecting pathogens from patients clinically diagnosed as acute hematogenous osteomyelitis (AHO). METHODS: This retrospective study enrolled 66 patients with AHO. The test results of mNGS and bacterial culture on different samples, including blood and puncture fluid samples, from patients with AHO were compared to explore the diagnostic value of blood mNGS. Besides, this study also explored the efficacy of blood mNGS in decision making for antibiotic administration and analyzed the factors associated with the positive result of blood mNGS. RESULTS: The most common causative pathogens were Staphylococcus and Streptococcus. The sensitivity of blood mNGS (77.3%) was higher than that of blood culture (42.4%) (P<0.001), while the turnaround time of blood mNGS (2.1 ± 0.4 d) is much less than that of blood culture (6.0 ± 2.1 d) (P<0.001). Besides, the sensitivity of blood mNGS tests (77.3%) was slightly lower than that of puncture fluid mNGS (89.4%). Furthermore, detection comparison at pathogen level unravels that blood mNGS might be suitable for diagnosing AHO caused by common pathogens, while puncture fluid mNGS could be considered as preferred examination in diagnosing AHO caused by uncommon pathogens. Finally, three independent factors associated with the true positive result of blood mNGS in patients with AHO were identified, including Gram-positive pathogens (OR=24.4, 95% CI = 1.4-421.0 for Staphylococcus; OR=14.9, 95%CI= 1.6-136.1 for other Gram-positive bacteria), body temperature at sampling time (OR=8.2, 95% CI = 0.6-107.3 for body temperature of >38.5°C; OR=17.2, 95% CI = 2.0-149.1 for patients who were chilling), and no use of antibiotics before sampling (OR=8.9, 95% CI =1.4-59.0). CONCLUSION: This is the first report on evaluating and emphasizing the importance of blood mNGS in diagnosing AHO. Blood sample might be an alternative sample for puncture fluid for mNGS, and its extensive application in diagnosing AHO could be expected.
format Online
Article
Text
id pubmed-9911542
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99115422023-02-11 The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis Zhang, Bingshi Chen, Xiao Yao, Xiaowei Li, Mengnan Li, Zhijie Liu, Bo Liu, Sikai Liu, Zeming Huo, Jia Han, Yongtai Front Cell Infect Microbiol Cellular and Infection Microbiology AIMS: This study aims to evaluate the diagnostic value of blood metagenomic next-generation sequencing (mNGS) in detecting pathogens from patients clinically diagnosed as acute hematogenous osteomyelitis (AHO). METHODS: This retrospective study enrolled 66 patients with AHO. The test results of mNGS and bacterial culture on different samples, including blood and puncture fluid samples, from patients with AHO were compared to explore the diagnostic value of blood mNGS. Besides, this study also explored the efficacy of blood mNGS in decision making for antibiotic administration and analyzed the factors associated with the positive result of blood mNGS. RESULTS: The most common causative pathogens were Staphylococcus and Streptococcus. The sensitivity of blood mNGS (77.3%) was higher than that of blood culture (42.4%) (P<0.001), while the turnaround time of blood mNGS (2.1 ± 0.4 d) is much less than that of blood culture (6.0 ± 2.1 d) (P<0.001). Besides, the sensitivity of blood mNGS tests (77.3%) was slightly lower than that of puncture fluid mNGS (89.4%). Furthermore, detection comparison at pathogen level unravels that blood mNGS might be suitable for diagnosing AHO caused by common pathogens, while puncture fluid mNGS could be considered as preferred examination in diagnosing AHO caused by uncommon pathogens. Finally, three independent factors associated with the true positive result of blood mNGS in patients with AHO were identified, including Gram-positive pathogens (OR=24.4, 95% CI = 1.4-421.0 for Staphylococcus; OR=14.9, 95%CI= 1.6-136.1 for other Gram-positive bacteria), body temperature at sampling time (OR=8.2, 95% CI = 0.6-107.3 for body temperature of >38.5°C; OR=17.2, 95% CI = 2.0-149.1 for patients who were chilling), and no use of antibiotics before sampling (OR=8.9, 95% CI =1.4-59.0). CONCLUSION: This is the first report on evaluating and emphasizing the importance of blood mNGS in diagnosing AHO. Blood sample might be an alternative sample for puncture fluid for mNGS, and its extensive application in diagnosing AHO could be expected. Frontiers Media S.A. 2023-01-27 /pmc/articles/PMC9911542/ /pubmed/36779189 http://dx.doi.org/10.3389/fcimb.2023.1106097 Text en Copyright © 2023 Zhang, Chen, Yao, Li, Li, Liu, Liu, Liu, Huo and Han https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Zhang, Bingshi
Chen, Xiao
Yao, Xiaowei
Li, Mengnan
Li, Zhijie
Liu, Bo
Liu, Sikai
Liu, Zeming
Huo, Jia
Han, Yongtai
The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title_full The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title_fullStr The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title_full_unstemmed The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title_short The diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
title_sort diagnostic value of blood metagenomic next-generation sequencing in patients with acute hematogenous osteomyelitis
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911542/
https://www.ncbi.nlm.nih.gov/pubmed/36779189
http://dx.doi.org/10.3389/fcimb.2023.1106097
work_keys_str_mv AT zhangbingshi thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT chenxiao thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT yaoxiaowei thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT limengnan thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT lizhijie thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT liubo thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT liusikai thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT liuzeming thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT huojia thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT hanyongtai thediagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT zhangbingshi diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT chenxiao diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT yaoxiaowei diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT limengnan diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT lizhijie diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT liubo diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT liusikai diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT liuzeming diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT huojia diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis
AT hanyongtai diagnosticvalueofbloodmetagenomicnextgenerationsequencinginpatientswithacutehematogenousosteomyelitis